Kalium-Natrium-Glucose Braun (Glucose, Anhydrous, Potassium Chloride, Sodium Chloride)

The sodium and potassium salts replenish extracellular electrolytes, while the glucose supplies immediate energy and stimulates insulin release, which helps shift potassium into cells. Together they restore fluid balance, correct electrolyte disturbances and provide metabolic support.

The prescribed dose is determined by the treating physician based on the patient’s clinical condition, electrolyte levels, and fluid requirements. Dosage is individualized and administered intravenously under medical supervision.

Safety data for use in pregnancy or lactation are limited. The product should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.

Unlike simple saline solutions, Kalium‑Natrium‑Glucose Braun contains both potassium and sodium salts plus glucose, offering combined electrolyte replacement and energy provision. This makes it suitable for situations where both electrolyte balance and rapid glucose supplementation are required, whereas standard saline lacks potassium and glucose.

The product should be stored at 2‑8 °C, protected from light, and must not be frozen or shaken. Keep the vial in its original packaging until use and discard any solution that appears discolored or contains particles.

It is administered intravenously by a qualified healthcare professional. The solution is typically infused through a peripheral or central venous line, with the rate adjusted according to the patient’s electrolyte status, fluid needs and clinical response.

Serious risks include severe hyperkalemia or hypernatremia, which can cause cardiac arrhythmias, volume overload leading to pulmonary edema, and rare anaphylactic reactions. Continuous monitoring of electrolytes and cardiac function is essential during infusion.

Patients with known hypersensitivity to any component, severe renal impairment without dose adjustment, uncontrolled hyperkalemia or hypernatremia, and those at high risk of fluid overload (e.g., severe heart failure) should not receive this product unless a physician determines it is absolutely necessary.